{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:31:26Z","timestamp":1793766686520,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010638","name":"Huntsman Cancer Institute, University of Utah","doi-asserted-by":"publisher","award":["NCT05557643"],"award-info":[{"award-number":["NCT05557643"]}],"id":[{"id":"10.13039\/100010638","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpainsymman.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T11:06:57Z","timestamp":1686395217000},"page":"258-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-1053","authenticated-orcid":false,"given":"Benjamin R.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-5273","authenticated-orcid":false,"given":"Kevin","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Durns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thielking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0001","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0002","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0003","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0004","article-title":"Assessment of psilocybin therapy for patients with cancer and major depression disorder","volume":"13","author":"Agrawal","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0006","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0008","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"Rebus and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0009","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120096","article-title":"Psilocybin-assisted psychotherapy for depression: emerging research on a psychedelic compound with a rich history","volume":"434","author":"Pearson","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0011","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","article-title":"Psychiatry & the psychedelic drugs. Past, present & future","volume":"142","author":"Rucker","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0012","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0013","series-title":"Peyote: History, Tradition, Politics, and Conservation","author":"Labate","year":"2016"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/02791072.2019.1593559","article-title":"Psychedelic-assisted group therapy: a systematic review","volume":"51","author":"Trope","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.749788","article-title":"Examining psychedelic-induced changes in social functioning and connectedness in a naturalistic online sample using the five-factor model of personality","volume":"12","author":"Weiss","year":"2021","journal-title":"Front Psychol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0017","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of psilocybin on empathy and moral decision-making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0019","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1017\/S2045796019000829","article-title":"Psychiatric and psychosocial implications in cancer care: the agenda of psycho-oncology","volume":"29","author":"Grassi","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.624902","article-title":"Cancer and relationship dissolution: perspective of partners of cancer patients","volume":"12","author":"Nalbant","year":"2021","journal-title":"Front Psychol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1037\/a0013348","article-title":"Meaning making and psychological adjustment following cancer: the mediating roles of growth, life meaning, and restored just-world beliefs","volume":"76","author":"Park","year":"2008","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0022","series-title":"The human quest for meaning: theories, research, and applications","first-page":"521","article-title":"Meaning and meaning making in cancer survivorship","author":"Park","year":"2012"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0023","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/jnci\/94.8.558","article-title":"For the NSW cancer council cancer education research program. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research","volume":"94","author":"Newell","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0025","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0026","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0027","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1207\/S15324796ABM2401_06","article-title":"Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy\u2013spiritual well-being scale (FACIT-Sp)","volume":"24","author":"Peterman","year":"2002","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0028","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0029","article-title":"Death Transcendence Scale [Database record]","author":"Hood","year":"1983","journal-title":"APA PsycTests."},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0030","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0031","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1200\/JCO.2014.57.2198","article-title":"Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer","volume":"33","author":"Breitbart","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0032","doi-asserted-by":"crossref","first-page":"98","DOI":"10.12688\/f1000research.2-98.v1","article-title":"Over 30 million psychedelic users in the United States","volume":"2","author":"Krebs","year":"2013","journal-title":"F1000Res"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0033","unstructured":"Ross LK. Psymposia [Internet]. 2022; Available at: https:\/\/www.psymposia.com\/powertrip\/"},{"key":"10.1016\/j.jpainsymman.2023.06.006_bib0034","first-page":"1","article-title":"Group format psychedelic-assisted therapy interventions: observations and impressions from the HOPE trial","volume":"1","author":"Lewis","year":"2023","journal-title":"Studies [Internet]"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423005304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423005304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:31:08Z","timestamp":1788233468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392423005304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0885392423005304"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.06.006","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}